Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Prostate Cancer

  Free Subscription


01.06.2026

3 Anticancer Res
2 BMC Cancer
2 BMC Urol
2 Cancer
1 Cancer Lett
2 Endocrinology
1 Eur J Radiol
4 Eur Radiol
1 Int J Radiat Oncol Biol Phys
1 Int J Urol
1 J Urol
1 Mod Pathol
2 Nat Rev Urol
1 PLoS Comput Biol
5 Prostate
1 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Anticancer Res

  1. YAMADA Y, Matsumoto M, Ikehara M, Tsujino T, et al
    Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate Cancer.
    Anticancer Res. 2026;46:3461-3472.
    PubMed         Abstract available

  2. YAMAMOTO Y, Matsumura N, Fujimoto S, Morita T, et al
    Predictive Role of PSA Kinetics in Oncological Outcomes of Metastatic Castration-sensitive Prostate Cancer.
    Anticancer Res. 2026;46:3383-3393.
    PubMed         Abstract available

  3. LEE J, Yoon J, Lee JY, Song YS, et al
    Milk Extracellular Vesicle-mediated Delivery of siPRNP Suppresses Growth and Wound Closure in PC-3M Prostate Cancer Cells.
    Anticancer Res. 2026;46:3145-3157.
    PubMed         Abstract available


    BMC Cancer

  4. WANG C, Zhang YY, Wang HQ, Huang C, et al
    Correction: AHSP as a novel non-invasive urinary biomarker for prostate cancer.
    BMC Cancer. 2026;26:682.
    PubMed        

  5. WEI C, Cai Y, Huang Z, Dai J, et al
    Comparative fall risk of patients treated with novel androgen receptor antagonists in prostate cancer: a systematic review and meta-analysis.
    BMC Cancer. 2026 May 23. doi: 10.1186/s12885-026-16146.
    PubMed         Abstract available


    BMC Urol

  6. OZDEMIR O
    Aggressive chronic prostatitis mimicking locally advanced prostate cancer with apparent extraprostatic extension: a case report.
    BMC Urol. 2026 May 27. doi: 10.1186/s12894-026-02195.
    PubMed         Abstract available

  7. XIAN P, Li P, Yuan G, Dai J, et al
    Lack of real-world evidence on active surveillance in Chinese patients with prostate cancer: insights from a 10-year cohort and a physician survey.
    BMC Urol. 2026 May 25. doi: 10.1186/s12894-026-02193.
    PubMed         Abstract available


    Cancer

  8. PIWARSKI SA, Howard LE, Paul MA, Bachelder N, et al
    Genetic ancestry-concordant ceramide metabolism and response to androgen receptor pathway inhibition in metastatic castration-resistant prostate cancer.
    Cancer. 2026;132:e70371.
    PubMed         Abstract available

  9. ZENG J, Chen MH, Wu J, Xie W, et al
    Testosterone and docetaxel treatment effect on mortality risk in nonmetastatic high-risk prostate cancer: A predictive biomarker analysis.
    Cancer. 2026;132:e70469.
    PubMed         Abstract available


    Cancer Lett

  10. MAZA PAMA, Flores L, Cyril-Ramirez D, Neeli P, et al
    Nanoplasmid PSMA DNA vaccine primes antitumor immunity and enhances response to PD-1 blockade against prostate cancer.
    Cancer Lett. 2026 May 22:218591. doi: 10.1016/j.canlet.2026.218591.
    PubMed         Abstract available


    Endocrinology

  11. ROBAYO P, Kazanietz MG, Baker MJ, Cooke M, et al
    FARP1 Mediates cMET-Driven Motility in Androgen-Independent Prostate Cancer Cells.
    Endocrinology. 2026 May 23:bqag062. doi: 10.1210.
    PubMed         Abstract available

  12. ZHANG M, Liu X
    Metabolic Plasticity and Enzalutamide Resistance: Emerging Roles of PGK1 in Prostate Cancer.
    Endocrinology. 2026 May 24:bqag063. doi: 10.1210.
    PubMed         Abstract available


    Eur J Radiol

  13. ALTAN SA, Sakar R, Onay A, Kizil PG, et al
    Prostate imaging after focal ablation scoring after irreversible electroporation treatment in localized prostate cancer: Diagnostic accuracy and inter-reader agreement.
    Eur J Radiol. 2026;202:112948.
    PubMed         Abstract available


    Eur Radiol

  14. POOCH EHP, Agrotis G, Cai L, Emberton M, et al
    Semi-supervised learning in prostate MRI tumor detection approaches fully supervised performance on external validation.
    Eur Radiol. 2026;36:5011-5021.
    PubMed         Abstract available

  15. WOO S, Curti F, Vargas HA
    Is PSMA PET/CT the answer to MRI-occult prostate cancer? Yes, but with strings attached.
    Eur Radiol. 2026 May 27. doi: 10.1007/s00330-026-12664.
    PubMed        

  16. WOO S, Tong A, Becker AS, Friedman KP, et al
    Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results.
    Eur Radiol. 2026;36:5068-5081.
    PubMed         Abstract available

  17. DURMAZ S, Wu SJ, Lee KL, Shakur A, et al
    The effects of prostate volume and PI-RADS category on optimal PSA-density thresholds for biopsy decision-making.
    Eur Radiol. 2026;36:4503-4512.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  18. ROY S, Jia AY, Zaorsky NG, Spratt DE, et al
    Elective Nodal Radiotherapy in Localized Prostate Cancer: A Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2026 May 22:S0360-3016(26)00730.
    PubMed         Abstract available


    Int J Urol

  19. ANDO S, Del Aguila Moraga DA, Hoshina H, Kawahira H, et al
    Artificial Intelligence-Based Objective Evaluation of Nerve-Sparing Status Combined With Preserved Urethral Length Predicts Urinary Continence Recovery After Robot-Assisted Radical Prostatectomy.
    Int J Urol. 2026;33:e70514.
    PubMed         Abstract available


    J Urol

  20. FILON M, O'Neil B
    A Seminal Shift in Prostate Cancer Detection?
    J Urol. 2026 May 22:101097JU0000000000005117. doi: 10.1097/JU.0000000000005117.
    PubMed        


    Mod Pathol

  21. SALGUERO-LOPEZ J, Medina S, Serafin R, Wang R, et al
    AI-Informed Architectural Insights of Three-Dimensional Glandular Networks Identify Prostate Cancer Patients at a Higher Risk of Biochemical Recurrence.
    Mod Pathol. 2026 May 25:101018. doi: 10.1016/j.modpat.2026.101018.
    PubMed         Abstract available


    Nat Rev Urol

  22. KOEHLER D, Maurer T
    Prostatic acid phosphatase: a rediscovered target in prostate cancer.
    Nat Rev Urol. 2026 May 22. doi: 10.1038/s41585-026-01156.
    PubMed        

  23. ALI A, Mikutenaite M, Weischenfeldt J, Bristow RG, et al
    Single-cell and spatial RNA sequencing in prostate cancer.
    Nat Rev Urol. 2026 May 28. doi: 10.1038/s41585-026-01149.
    PubMed         Abstract available


    PLoS Comput Biol

  24. ZHANG R, Zhou J, Dong S, Liu G, et al
    Integrated computational and experimental analysis explores FOLH1 expression patterns across cancers and nominates melatonin as a potential modulator in prostate cancer models.
    PLoS Comput Biol. 2026;22:e1014315.
    PubMed         Abstract available


    Prostate

  25. STEIDLE MT, Malshy K, Cheng Z, Zhu D, et al
    Outcome Differences Between Subgroups of Favorable Intermediate Risk Prostate Cancer After Radical Prostatectomy.
    Prostate. 2026 May 26. doi: 10.1002/pros.70199.
    PubMed         Abstract available

  26. FIALA O, Tkadlecova M, Vachalova Z, Hora M, et al
    Prognostic Role of Serum Neuron-Specific Enolase at Baseline and its Early Dynamics in Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.
    Prostate. 2026 May 26. doi: 10.1002/pros.70197.
    PubMed         Abstract available

  27. GHOREIFI A, Alshalalfa M, Davicioni E, Spratt DE, et al
    Characterizing the Activity of Inflammasome-Related Genes and Their Association With Oncological Outcomes in Prostate Cancer.
    Prostate. 2026 May 26. doi: 10.1002/pros.70202.
    PubMed         Abstract available

  28. ASANUMA H, Fujita N, Kato S, Kawashima Y, et al
    Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Study.
    Prostate. 2026 May 26. doi: 10.1002/pros.70203.
    PubMed         Abstract available

  29. HIMMELSBACH R, Franz J, Jilg C, Gratzke C, et al
    Spatial Distribution of Prostate Cancer Missed by MRI-Targeted Biopsy, Effect of a Perilesional Template, and Restaging in a Radical Prostatectomy Cohort.
    Prostate. 2026 May 26. doi: 10.1002/pros.70201.
    PubMed         Abstract available


    Urology

  30. VARGHESE E, Chen J, Kwan L, Litwin MS, et al
    Frailty and Quality of Life in Low-Income, Uninsured Men with Prostate Cancer.
    Urology. 2026 May 21:S0090-4295(26)00319-5. doi: 10.1016/j.urology.2026.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum